A molecular stabiliser of an inhibitory eIF2B-eIF2(αP) complex activates the Integrated Stress Response.
Saved in:
| Title: | A molecular stabiliser of an inhibitory eIF2B-eIF2(αP) complex activates the Integrated Stress Response. |
|---|---|
| Authors: | Shilliday F; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK. fiona.shilliday@astrazeneca.com., Gancedo-Rodrigo M; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., George G; Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK., Aibara S; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Adhikari S; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Ashraf SN; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Barrey EJ; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Centrella PA; X-Chem Inc., Waltham, Massachusetts, USA., Crowther D; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Dickson P; X-Chem Inc., Waltham, Massachusetts, USA., Gikunju D; X-Chem Inc., Waltham, Massachusetts, USA., Guié MA; X-Chem Inc., Waltham, Massachusetts, USA., Guilinger JP; X-Chem Inc., Waltham, Massachusetts, USA., Gunnarsson A; Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Harding HP; Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK., Hupp CD; X-Chem Inc., Waltham, Massachusetts, USA., Jetson R; X-Chem Inc., Waltham, Massachusetts, USA., Keefe AD; X-Chem Inc., Waltham, Massachusetts, USA., Kim JM; Neuroscience, R&D, AstraZeneca, Cambridge, UK., Lewis RJ; Department of Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Maia de Oliveira T; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Le-Marshall J; X-Chem Inc., Waltham, Massachusetts, USA., Narayanan U; X-Chem Inc., Waltham, Massachusetts, USA., Nugai KA; X-Chem Inc., Waltham, Massachusetts, USA., Petrović D; Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Rivers E; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Ron D; Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK., Stringfellow D; Neuroscience, R&D, AstraZeneca, Cambridge, UK., Syson K; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Ward L; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Yeoman JTS; X-Chem Inc., Waltham, Massachusetts, USA., Yu Y; X-Chem Inc., Waltham, Massachusetts, USA., Zhang Y; X-Chem Inc., Waltham, Massachusetts, USA., Zyryanova A; Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK., Baker DJ; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Breccia P; Neuroscience, R&D, AstraZeneca, Cambridge, UK., Linley JE; Neuroscience, R&D, AstraZeneca, Cambridge, UK. |
| Source: | Nature communications [Nat Commun] 2026 May 06. Date of Electronic Publication: 2026 May 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42091608 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A molecular stabiliser of an inhibitory eIF2B-eIF2(αP) complex activates the Integrated Stress Response. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shilliday+F%22">Shilliday F</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK. fiona.shilliday@astrazeneca.com.<br /><searchLink fieldCode="AU" term="%22Gancedo-Rodrigo+M%22">Gancedo-Rodrigo M</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22George+G%22">George G</searchLink>; Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Aibara+S%22">Aibara S</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Adhikari+S%22">Adhikari S</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Ashraf+SN%22">Ashraf SN</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Barrey+EJ%22">Barrey EJ</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Centrella+PA%22">Centrella PA</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Crowther+D%22">Crowther D</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Dickson+P%22">Dickson P</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Gikunju+D%22">Gikunju D</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Guié+MA%22">Guié MA</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Guilinger+JP%22">Guilinger JP</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Gunnarsson+A%22">Gunnarsson A</searchLink>; Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Harding+HP%22">Harding HP</searchLink>; Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Hupp+CD%22">Hupp CD</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Jetson+R%22">Jetson R</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Keefe+AD%22">Keefe AD</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Kim+JM%22">Kim JM</searchLink>; Neuroscience, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Lewis+RJ%22">Lewis RJ</searchLink>; Department of Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Maia+de+Oliveira+T%22">Maia de Oliveira T</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Le-Marshall+J%22">Le-Marshall J</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Narayanan+U%22">Narayanan U</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Nugai+KA%22">Nugai KA</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Petrović+D%22">Petrović D</searchLink>; Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Rivers+E%22">Rivers E</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Ron+D%22">Ron D</searchLink>; Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Stringfellow+D%22">Stringfellow D</searchLink>; Neuroscience, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Syson+K%22">Syson K</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Ward+L%22">Ward L</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Yeoman+JTS%22">Yeoman JTS</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Yu+Y%22">Yu Y</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; X-Chem Inc., Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Zyryanova+A%22">Zyryanova A</searchLink>; Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Baker+DJ%22">Baker DJ</searchLink>; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Breccia+P%22">Breccia P</searchLink>; Neuroscience, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Linley+JE%22">Linley JE</searchLink>; Neuroscience, R&D, AstraZeneca, Cambridge, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2026 May 06. <i>Date of Electronic Publication: </i>2026 May 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42091608 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-026-72688-y Languages: – Code: eng Text: English Titles: – TitleFull: A molecular stabiliser of an inhibitory eIF2B-eIF2(αP) complex activates the Integrated Stress Response. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shilliday F – PersonEntity: Name: NameFull: Gancedo-Rodrigo M – PersonEntity: Name: NameFull: George G – PersonEntity: Name: NameFull: Aibara S – PersonEntity: Name: NameFull: Adhikari S – PersonEntity: Name: NameFull: Ashraf SN – PersonEntity: Name: NameFull: Barrey EJ – PersonEntity: Name: NameFull: Centrella PA – PersonEntity: Name: NameFull: Crowther D – PersonEntity: Name: NameFull: Dickson P – PersonEntity: Name: NameFull: Gikunju D – PersonEntity: Name: NameFull: Guié MA – PersonEntity: Name: NameFull: Guilinger JP – PersonEntity: Name: NameFull: Gunnarsson A – PersonEntity: Name: NameFull: Harding HP – PersonEntity: Name: NameFull: Hupp CD – PersonEntity: Name: NameFull: Jetson R – PersonEntity: Name: NameFull: Keefe AD – PersonEntity: Name: NameFull: Kim JM – PersonEntity: Name: NameFull: Lewis RJ – PersonEntity: Name: NameFull: Maia de Oliveira T – PersonEntity: Name: NameFull: Le-Marshall J – PersonEntity: Name: NameFull: Narayanan U – PersonEntity: Name: NameFull: Nugai KA – PersonEntity: Name: NameFull: Petrović D – PersonEntity: Name: NameFull: Rivers E – PersonEntity: Name: NameFull: Ron D – PersonEntity: Name: NameFull: Stringfellow D – PersonEntity: Name: NameFull: Syson K – PersonEntity: Name: NameFull: Ward L – PersonEntity: Name: NameFull: Yeoman JTS – PersonEntity: Name: NameFull: Yu Y – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Zyryanova A – PersonEntity: Name: NameFull: Baker DJ – PersonEntity: Name: NameFull: Breccia P – PersonEntity: Name: NameFull: Linley JE IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 05 Text: 2026 May 06 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2041-1723 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |